Superior Mesenteric Artery Thrombosis Following Severe COVID-19 Pneumonia

Posted on | Posted on John Murphy | Leave a Comment on Superior Mesenteric Artery Thrombosis Following Severe COVID-19 Pneumonia

Authors: Abdulhadi A Alali,1Mohammed O Baqais,2Fayez M Albishi,3, et. al. Cureus. (11):19954. doi: 10.7759/cureus.19954PMCID: PMC8713302PMID: 34976537 Abstract Thrombotic events are well-recognized complications of coronavirus disease 2019 (COVID-19). The incidence of such complications is highly related to the severity of COVID-19 pneumonia. Recent evidence suggests that the coagulopathy of COVID-19 may persist for some period even after the full recovery from […]

COVID-19 Linked To Alzheimer’s-Like Brain Changes, Study Suggests

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Linked To Alzheimer’s-Like Brain Changes, Study Suggests

Authors: Jennifer Margulis via The Epoch Times  For some, it’s just a sniffle. But for others, COVID-19 can hit hard. Either way, some people who get COVID-19 will suffer from long-term effects. This is known as “long COVID,” and its sufferers are often referred to as “long haulers.” Chances are you already know about long COVID and you […]

The Invisible Damage: How COVID Rewires Our Brains

Posted on | Posted on John Murphy | Leave a Comment on The Invisible Damage: How COVID Rewires Our Brains

By University of Colorado at Boulder, University of Colorado Boulder scientists have discovered that proteins left by COVID-19 can significantly lower cortisol levels in the brain, leading to heightened immune responses to new stressors. This research, focusing on the neurological symptoms of Long COVID, utilized rats to demonstrate how SARS-CoV-2 antigens persist in the body and alter brain function. This […]

Common skin signs of COVID-19 in adults: An update

Posted on | Posted on John Murphy | Leave a Comment on Common skin signs of COVID-19 in adults: An update

Samantha Polly, MD and Anthony P. Fernandez, MD, PhD Cleveland Clinic Journal of Medicine March 2022, 89 (3) 161-167; DOI:, https://doi.org/10.3949/ccjm.89a.21126 ABSTRACT Cutaneous findings can be clues to diagnosis and infection severity in viral illnesses, including COVID-19. The authors provide an update on the diagnostic and prognostic value of the 5 most common cutaneous abnormalities associated with COVID-19 in adult patients: morbilliform rash, urticaria, vesicles, pseudo-chilblains, […]

Did CDC Officials Mislead The Public About COVID Vaccine Efficacy? Rep. Massie Says “Yes”

Posted on | Posted on John Murphy | Leave a Comment on Did CDC Officials Mislead The Public About COVID Vaccine Efficacy? Rep. Massie Says “Yes”

Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the newly released Covid vaccine would benefit him, since he’d already contracted the illness. After reading the scientific studies himself, and seeing no benefit, Massie contacted […]

Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice 

Posted on | Posted on John Murphy | Leave a Comment on Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice 

Esther E Freeman, Ignacio Garcia-Doval, Luigi Naldi, Roderick J Hay British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 1–, https://doi.org/10.1093/bjd/ljad131 In early 2020 there were reports of a new and potentially fatal viral infection affecting large numbers of people in Wuhan, China. Over the following 3 months it had spread throughout most of the world, with all countries […]

DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS

Posted on | Posted on John Murphy | Leave a Comment on DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS

Originally published on The Lancet Infectious Disease KEY FINDINGS Study Methods In April 2020, working with the International League of Dermatological Societies and the American Academy of Dermatology, the researchers established an international registry for health care providers to report COVID-19 dermatologic signs and symptoms. Overall Duration of Signs/Symptoms Between April 8 and October 8, 2020, clinicians from 41 […]

Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection 

Posted on | Posted on John Murphy | Leave a Comment on Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection 

Zoe O Demko, Tong Yu, Sarika K Mullapudi, M Gabriela Varela Heslin, et. al. Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027 Abstract Background Few longitudinal studies available characterize long COVID outcomes out to 24 months, especially in people with nonsevere acute coronavirus disease 2019 (COVID-19). This study sought to prospectively characterize incidence and duration of […]

Role of MicroRNA-21 in Regulating Intracellular Pathways Associated With Phagocytosis in Human Macrophages: An In Vitro Study

Posted on | Posted on John Murphy | Leave a Comment on Role of MicroRNA-21 in Regulating Intracellular Pathways Associated With Phagocytosis in Human Macrophages: An In Vitro Study

Natsuki Anada • Yoshinobu Nakayama • Jun Takeshita • Kyoko Kageyama • Hiroatsu Sakamoto • Takahiko Kamibayashi • Yasufumi Nakajima 2024, DOI: 10.7759/cureus.63736  Abstract Introduction The efficient clearance of bacteria by macrophages is crucial for the timely resolution of inflammation. In this study, we investigated the role of microRNA-21 (miR-21)-induced phagocytosis and its intracellular signaling pathways in human macrophages in vitro. Methods Human peripheral blood mononuclear cells (PBMCs) were […]

IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo

Posted on | Posted on John Murphy | Leave a Comment on IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo

Shreya Ghimire, Biyun Xue, Kun Li, Ryan M Gannon, et. al.doi: https://doi.org/10.1101/2024.07.03.60194 Abstract Treatments available to prevent progression of virus-induced lung diseases, including coronavirus disease 2019 (COVID-19) are of limited benefit once respiratory failure occurs. The efficacy of approved and emerging cytokine signaling-modulating antibodies is variable and is affected by disease course and patient-specific inflammation patterns. Therefore, understanding the role of inflammation on the […]